Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03902496|
Recruitment Status : Completed
First Posted : April 4, 2019
Last Update Posted : July 5, 2019
All versions of ACT results information submissions that have not completed the QC review process are posted on ClinicalTrials.gov (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||May 17, 2019|
|Actual Study Completion Date :||May 17, 2019|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
July 10, 2020 ||July 27, 2020 Submission with QC Comments|
January 12, 2021 ||January 29, 2021 Submission with QC Comments|